Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for INVA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
June 30, 2026 29.40M
March 31, 2026 20.15M
December 31, 2025 3.721M
September 30, 2025 -10.87M
June 30, 2025 -1.247M
March 31, 2025 -0.183M
December 31, 2024 -0.573M
September 30, 2024 -0.211M
June 30, 2024 5.072M
March 31, 2024 9.165M
December 31, 2023 14.59M
September 30, 2023 11.08M
June 30, 2023 9.206M
March 31, 2023 40.76M
December 31, 2022 8.486M
September 30, 2022 0.011M
June 30, 2022 -0.068M
March 31, 2022 -0.214M
December 31, 2021 -1.033M
September 30, 2021 -0.051M
June 30, 2021 394.10M
March 31, 2021 0.025M
December 31, 2020 -0.006M
September 30, 2020 0.012M
June 30, 2020 -0.18M
Date Value
March 31, 2020 -0.17M
December 31, 2019 -0.001M
September 30, 2019 -0.082M
June 30, 2019 -0.201M
March 31, 2019 -0.254M
December 31, 2018 -0.694M
September 30, 2018 0.242M
June 30, 2018 -0.111M
March 31, 2018 2.497M
December 31, 2017 80.70M
September 30, 2017 17.83M
June 30, 2017 0.117M
March 31, 2017 0.545M
December 31, 2016 12.49M
September 30, 2016 21.52M
June 30, 2016 18.58M
March 31, 2016 25.63M
December 31, 2015 25.58M
September 30, 2015 -3.485M
June 30, 2015 -1.425M
March 31, 2015 -1.086M
December 31, 2014 -13.30M
September 30, 2014 -11.84M
June 30, 2014 -5.514M
March 31, 2014 -18.27M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Zevra Therapeutics, Inc. -0.435M
Collegium Pharmaceutical, Inc. -0.481M
CorMedix, Inc. 6.157M
ANI Pharmaceuticals, Inc. 0.505M
Corcept Therapeutics, Inc. -9.42M